rs12628

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005343.4(HRAS):​c.81T>C​(p.His27His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.331 in 1,612,572 control chromosomes in the GnomAD database, including 90,079 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.34 ( 9044 hom., cov: 33)
Exomes 𝑓: 0.33 ( 81035 hom. )

Consequence

HRAS
NM_005343.4 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:15O:1

Conservation

PhyloP100: 1.91

Publications

130 publications found
Variant links:
Genes affected
HRAS (HGNC:5173): (HRas proto-oncogene, GTPase) This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene. [provided by RefSeq, Jul 2008]
LRRC56 (HGNC:25430): (leucine rich repeat containing 56) Predicted to be involved in cell projection organization. Predicted to be located in cilium. Implicated in primary ciliary dyskinesia 39. [provided by Alliance of Genome Resources, Apr 2022]
LRRC56 Gene-Disease associations (from GenCC):
  • ciliary dyskinesia, primary, 39
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 11-534242-A-G is Benign according to our data. Variant chr11-534242-A-G is described in ClinVar as Benign. ClinVar VariationId is 40431.Status of the report is reviewed_by_expert_panel, 3 stars.
BP7
Synonymous conserved (PhyloP=1.91 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.375 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005343.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HRAS
NM_005343.4
MANE Select
c.81T>Cp.His27His
synonymous
Exon 2 of 6NP_005334.1P01112-1
HRAS
NM_176795.5
MANE Plus Clinical
c.81T>Cp.His27His
synonymous
Exon 2 of 6NP_789765.1P01112-2
HRAS
NM_001130442.3
c.81T>Cp.His27His
synonymous
Exon 2 of 5NP_001123914.1X5D945

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HRAS
ENST00000311189.8
TSL:1 MANE Select
c.81T>Cp.His27His
synonymous
Exon 2 of 6ENSP00000309845.7P01112-1
HRAS
ENST00000417302.7
TSL:5 MANE Plus Clinical
c.81T>Cp.His27His
synonymous
Exon 2 of 6ENSP00000388246.1P01112-2
HRAS
ENST00000493230.5
TSL:1
n.81T>C
non_coding_transcript_exon
Exon 2 of 7ENSP00000434023.1P01112-2

Frequencies

GnomAD3 genomes
AF:
0.341
AC:
51764
AN:
151950
Hom.:
9032
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.380
Gnomad AMI
AF:
0.353
Gnomad AMR
AF:
0.373
Gnomad ASJ
AF:
0.268
Gnomad EAS
AF:
0.187
Gnomad SAS
AF:
0.252
Gnomad FIN
AF:
0.257
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.344
Gnomad OTH
AF:
0.335
GnomAD2 exomes
AF:
0.316
AC:
79100
AN:
250438
AF XY:
0.311
show subpopulations
Gnomad AFR exome
AF:
0.381
Gnomad AMR exome
AF:
0.381
Gnomad ASJ exome
AF:
0.271
Gnomad EAS exome
AF:
0.187
Gnomad FIN exome
AF:
0.267
Gnomad NFE exome
AF:
0.339
Gnomad OTH exome
AF:
0.311
GnomAD4 exome
AF:
0.330
AC:
482463
AN:
1460504
Hom.:
81035
Cov.:
34
AF XY:
0.328
AC XY:
238255
AN XY:
726624
show subpopulations
African (AFR)
AF:
0.375
AC:
12539
AN:
33454
American (AMR)
AF:
0.376
AC:
16833
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.271
AC:
7074
AN:
26124
East Asian (EAS)
AF:
0.179
AC:
7114
AN:
39694
South Asian (SAS)
AF:
0.254
AC:
21876
AN:
86252
European-Finnish (FIN)
AF:
0.278
AC:
14723
AN:
53054
Middle Eastern (MID)
AF:
0.270
AC:
1558
AN:
5766
European-Non Finnish (NFE)
AF:
0.344
AC:
381912
AN:
1111100
Other (OTH)
AF:
0.312
AC:
18834
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
16685
33371
50056
66742
83427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12200
24400
36600
48800
61000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.341
AC:
51809
AN:
152068
Hom.:
9044
Cov.:
33
AF XY:
0.336
AC XY:
25012
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.380
AC:
15758
AN:
41486
American (AMR)
AF:
0.373
AC:
5704
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.268
AC:
931
AN:
3470
East Asian (EAS)
AF:
0.187
AC:
968
AN:
5168
South Asian (SAS)
AF:
0.253
AC:
1216
AN:
4814
European-Finnish (FIN)
AF:
0.257
AC:
2721
AN:
10592
Middle Eastern (MID)
AF:
0.265
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
0.344
AC:
23398
AN:
67946
Other (OTH)
AF:
0.338
AC:
714
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1828
3656
5485
7313
9141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.341
Hom.:
7725
Bravo
AF:
0.348
Asia WGS
AF:
0.247
AC:
856
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
1
2
Costello syndrome (3)
-
-
3
not provided (4)
-
-
2
RASopathy (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Noonan syndrome and Noonan-related syndrome (1)
-
-
1
Squamous cell lung carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
5.7
DANN
Benign
0.82
PhyloP100
1.9
PromoterAI
-0.040
Neutral
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12628; hg19: chr11-534242; COSMIC: COSV54237196; COSMIC: COSV54237196; API